In the context of innovative haematological immunotherapies, often characterized by the onset of hyperinflammatory complications, the laboratory plays an increasingly strategic role in supporting the clinical decision-making process. This is what emerges from the scientific contribution presented by Giovanni Riva, Diagnostic Hematology, Department of Laboratory Medicine and Pathological Anatomy of the AUSL/AOU of Modena, at the International Con…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
In the context of innovative haematological immunotherapies, often characterized by the onset of hyperinflammatory complications, the laboratory plays an increasingly strategic role in supporting the clinical decision-making process. This is what emerges from the scientific contribution presented by Giovanni Riva, Diagnostic Hematology, Department of Laboratory Medicine and Pathological Anatomy of the AUSL/AOU of Modena, at the International Con…